December 12, 2018 / 11:54 AM / 10 months ago

BUZZ-Synergy Pharma: Jumps on deal to sell assets for $200 mln

** Drugmaker’s shares up 12.1 pct at $0.38 premarket after Canada’s Bausch Health Companies Inc agreed to buy all of its assets

** SGYP is the top pct gainer among U.S. stocks before the opening bell

** Deal for $200 mln in cash and includes all rights to SGYP’s lead drug Trulance, used to treat constipation

** To facilitate sale and address its debt, SGYP voluntarily filed for Chapter 11 bankruptcy

** Per terms of deal, Bausch Health will serve as “stalking horse” bidder in a court-supervised auction and sale process

** A stalking horse bid is an attempt by a bankrupt debtor to test the market for assets ahead of auctioning them, in order to maximize value of its assets and avoid low bids

** SGYP has lost 84 pct of its value this year (Reporting by Amy Caren Daniel in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below